LVTX - LAVA Therapeutics NV
IEX Last Trade
1.745
-0.085 -4.871%
Share volume: 51,223
Last Updated: Fri 30 Aug 2024 09:59:36 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.83
-0.09
-4.65%
View ratios
Fiscal Date | |
---|---|
Fiscal Quarter | |
Report Date | |
Total revenue | |
Cost of revenue | |
Gross profit | |
Operating expenses | |
Selling general and admin | |
Research and development | |
Total expenses | |
Operating income | |
Ebit | |
Pretax income | |
Income tax | |
Net income basic | |
Net income |